Buy Crypto Markets Spot FuturesZEC Earn Event Center Rewards Hub

Salarius Pharmaceuticals, Inc. (SLRX)

NASDAQ

$--

(--)

Pre-Market

Salarius Pharmaceuticals, Inc. (SLRX) Live Price Chart

Last updated: ⁦2026-09-08 08:35:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Salarius Pharmaceuticals, Inc. (SLRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Salarius Pharmaceuticals, Inc. (SLRX) Pre-Market Stock Price

Salarius Pharmaceuticals, Inc. (SLRX) is trading at $-- in pre-market trading as of --, -- from the previous close of $--

Pre-market trading shows how investors are pricing SLRX before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.

Salarius Pharmaceuticals, Inc. (SLRX) 7-Day Stock Price Change

Over the past seven days, Salarius Pharmaceuticals, Inc. (SLRX) moved from $0.66 to $0.84, representing a gain of 28.21% ($0.18).

The stock traded between $0.51 and $0.90 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 1.30 million shares, up versus the previous seven-day period, indicating higher trading activity.

What is Salarius Pharmaceuticals, Inc. (SLRX)?

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

Salarius Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	2
Exchange	NASDAQ
Company Website	https://www.salariuspharma.com

How to Buy Salarius Pharmaceuticals, Inc. (SLRX) Stock on MEXC

Eligible investors can buy real shares of Salarius Pharmaceuticals, Inc. (SLRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for SLRX and Place Your Order

Open the RealStocks trading page and search for SLRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Salarius Pharmaceuticals, Inc. (SLRX) stock price today?

Salarius Pharmaceuticals, Inc. (SLRX) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is SLRX stock going up or down today?

As of --, SLRX is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is SLRX pre-market price?

As of --, SLRX is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is SLRX after-hours price?

As of --, SLRX is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is SLRX stock trading now?

SLRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does SLRX sit relative to its 52-week high and low?

Over the past 52 weeks, SLRX has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Salarius Pharmaceuticals, Inc. in?

Salarius Pharmaceuticals, Inc. (SLRX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Salarius Pharmaceuticals, Inc.'s market capitalization and where is it listed?

Salarius Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is SLRX valued in terms of P/E ratio and EPS?

SLRX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Salarius Pharmaceuticals, Inc. pay a dividend?

Salarius Pharmaceuticals, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.